Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
10.1110/ps.9.12.2436 Protein Sci
Clinical studies have demonstrated that GLP-1 receptor agonists can reduce various inflammatory biomarkers , including: C-reactive protein (CRP) : A general marker of systemic inflammation Interleukin-6 (IL-6) : A pro-inflammatory cytokine Tumour necrosis factor-alpha (TNF-) : Another key inflammatory mediator Plasminogen activator inhibitor-1 (PAI-1) : Associated with cardiovascular inflammation The magnitude of these effects varies between studies and may depend on baseline inflammatory status, degree of weight loss achieved, and individual patient characteristics
Although researchers did not observe significant changes in body weight, body mass index (BMI), waist-to-hip ratio, lean body mass, or total body fat percentage, participants demonstrated improvements in several measures of muscle strength and muscular endurance (2)
You can view the published Institute BCN Advanced Protocols by clicking the link
Other approaches to fat loss exist
